Skip to main content
Equibles

MORGAN STANLEY

Position in ALGS — Aligos Therapeutics, Inc.

CIK 895421 NEW YORK, NY
Back to ALGS Full portfolio

Position in ALGS

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$1,176
-$442 QoQ
Shares Held
204
-6.4% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#26
of 31 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority Sole 25% Shared 0% None 75%

Common Shares in ALGS Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

MORGAN STANLEY holds $16,838,649,954 across 523 Biotechnology names. ALGS ranks #466 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 RPRX
Royalty Pharma plc
 42,931,597 $2,407,174,637
2 VRTX
Vertex Pharmaceuticals Inc / Ma
 3,242,139 $1,610,467,694
3 ROIV
Roivant Sciences Ltd.
 42,592,905 $1,507,362,901
4 REGN
Regeneron Pharmaceuticals, Inc.
 1,397,712 $871,529,332
5 MRNA
Moderna, Inc.
 9,538,094 $667,952,718
6 ARGX
Argenx SE
 643,123 $596,670,219
7 TECH
BIO-TECHNE Corp
 6,374,717 $450,373,747
8 INCY
Incyte Corp
 2,948,364 $334,226,536

All Filings in ALGS

Export CSV
23 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,176 204
2026-03-31 $1,618 218
2025-12-31 $23,485 2,520
2025-09-30 $110,582 11,284
2025-06-30 $28,875 4,005
2025-03-31 $61,858 7,498
2024-12-31 $128,801 3,233
2024-09-30 $1,160 134
2024-06-30 $1,155 3,300
2024-03-31 $3,234 3,300
2023-12-31 $1,328 2,000
2023-09-30 $1,494 2,000
2023-06-30 $2,913 3,000
2023-03-31 $115,999 132,724
2022-12-31 $2,241 2,353
2022-09-30 $11,308 10,282
2022-06-30 $63,659 52,613
2022-03-31 $172,233 80,110
2021-12-31 $613,320 51,670
2021-09-30 $7,280,454 469,404
2021-06-30 $323,284 15,859
2021-03-31 $780,323 34,315
2020-12-31 $569,396 20,593